Skye Bioscience, Inc. Share Price
NASDAQ: SKYE | Micro CapSkye Bioscience, Inc. Stock Performance
Skye Bioscience, Inc. Share Price Today
As of 19 September 2026, Skye Bioscience, Inc.'s share price is $1.76. The stock opened at $1.84, compared to its previous close of $1.59. During today's trading session, Skye Bioscience, Inc.'s share price traded between $1.75 and $1.84, with an average price of $1.80. Over the past 52 weeks, the stock has recorded a high of $4.94 and a low of $0.28. In terms of performance, Skye Bioscience, Inc.'s share price has risen by 192.85% over the last six months and is down 54.99% on a year-on-year basis.
Skye Bioscience, Inc. Share Price Chart
Skye Bioscience, Inc. Quarterly Profit & Loss
All figures in USD
Skye Bioscience, Inc. Annual Profit & Loss
All figures in USD
About Skye Bioscience, Inc.
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.
Skye Bioscience, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $1.78 | $1.75 | -12.64% |
Aug 2026 | $0.57 | $2.01 | +242.25% |
Jul 2026 | $0.68 | $0.59 | -12.52% |
Jun 2026 | $0.79 | $0.67 | -13.42% |
May 2026 | $0.79 | $0.78 | -12.82% |
Apr 2026 | $0.68 | $0.89 | +47.92% |
Mar 2026 | $0.77 | $0.60 | -19.11% |
Feb 2026 | $0.92 | $0.74 | -26.44% |
Jan 2026 | $0.74 | $1.01 | +35.75% |
Dec 2025 | $1.25 | $0.74 | -43.85% |
Nov 2025 | $1.53 | $1.32 | -15.06% |
Oct 2025 | $3.94 | $1.56 | -60.10% |